Radiopharm Theranostics Ltd - ADR Live Stock Price Today, Share Analysis and Chart

Name: Radiopharm Theranostics Ltd - ADR: Is Infosys Ltd. worth buying?
Item: Radiopharm Theranostics Ltd - ADR
Rating: 0.80000
Author: Trendlyne DVM scores

about

Radiopharm Theranostics Ltd is an Australian based clinical-stage radiotherapeutics company which is targeting cancer. The company has a pipeline of around four licensed platform technologies, with diagnostic and therapeutic applications in both pre-...

4.64 -0.17 (-3.53%)

52W Low on Jul 03, 2025

12,218

XNAS Volume

XNAS 30 Jul, 2025 5:30 PM (EDT)

Not Eligible

Expensive Valuation

9.5 / 100

Technically Bearish

22.5 / 100

1Yr Price target upside is 272%

6 analysts

Radiopharm Theranostics Lt... Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..